Serum Protein Glycopatterns as Biomarkers for Machine Learning Diagnosis of Major Depressive Disorder.

Authors

Shiyi Wang, Jian Shu, Hanjie Yu, Yue Shi, Chen Zhang, Xinyuan Hu, Zheng Li

Published in

Glycobiology. Sep 21, 2026. Epub Sep 21, 2026.

Abstract

The diagnosis of major depressive disorder (MDD) currently relies on subjective clinical assessment, underscoring the need for objective biomarkers. Glycosylation, a common post-translational modification, is involved in neuroinflammation and immune regulation, both implicated in MDD pathogenesis. This study aimed to identify serum protein glycopatterns as biomarkers for MDD diagnosis and severity stratification. Serum samples from 150 individuals, including healthy volunteers (HV, n = 38), mild-to-moderate MDD (M-MDD, n = 52), and severe MDD (S-MDD, n = 60), were analyzed using lectin microarrays. Thirty-six lectins showed significantly altered binding signals that indicating widespread glycosylation changes between HV, M-MDD, and S-MDD. These features were used to train seven machine-learning models, among which K-nearest neighbours (KNN) performed best, achieving 95.3% ± 2.7% accuracy and an AUC (Micro) of 0.990 ± 0.010 in a nested 5-fold cross-validation framework. In a blinded cohort (n = 71), the KNN model showed accuracies of 0.831, 0.662, and 0.831 for MDD, M-MDD, and S-MDD, respectively. SHAP analysis identified key lectins contributing to classification. These results demonstrated that serum glycopatterns combined with machine learning provided a promising objective tool for MDD diagnosis and severity assessment.

PMID:
42765605
Bibliographic data and abstract were imported from PubMed on 21 Sep 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.